A Benzene, 1,3,5-trihydroxy- CEP of the European Pharmacopoeia monograph is often referred to as a Benzene, 1,3,5-trihydroxy- Certificate of Suitability (COS). The purpose of a Benzene, 1,3,5-trihydroxy- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Benzene, 1,3,5-trihydroxy- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Benzene, 1,3,5-trihydroxy- to their clients by showing that a Benzene, 1,3,5-trihydroxy- CEP has been issued for it. The manufacturer submits a Benzene, 1,3,5-trihydroxy- CEP (COS) as part of the market authorization procedure, and it takes on the role of a Benzene, 1,3,5-trihydroxy- CEP holder for the record. Additionally, the data presented in the Benzene, 1,3,5-trihydroxy- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Benzene, 1,3,5-trihydroxy- DMF.
A Benzene, 1,3,5-trihydroxy- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Benzene, 1,3,5-trihydroxy- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Benzene, 1,3,5-trihydroxy- suppliers with CEP (COS) on PharmaCompass.